Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer

OBJECTIVE: To assess the hormonal effects of Fem7® (Merck, KGaA, Darmstadt, Germany) 100 μg transdermal oestrogen patches on men undergoing first-line androgen-deprivation therapy for prostate cancer. PATIENTS AND METHODS: PATCH is a multicentre, randomized, phase II trial for men with locally advan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langley, Ruth E., Godsland, Ian F., Kynaston, Howard, Clarke, Noel W., Rosen, Stuart D., Morgan, Rachel C., Pollock, Philip, Kockelbergh, Roger, Lalani, El-Nasir, Dearnaley, David, Parmar, Mahesh, Abel, Paul D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2564109/
https://ncbi.nlm.nih.gov/pubmed/18422771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2008.07583.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados